METTLER-TOLEDO INTERNATIONAL (MTD) Stock Fundamental Analysis

NYSE:MTD • US5926881054

1372.1 USD
-3.47 (-0.25%)
Last: Feb 19, 2026, 01:56 PM
Fundamental Rating

5

MTD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. While MTD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MTD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year MTD was profitable.
  • MTD had a positive operating cash flow in the past year.
  • Each year in the past 5 years MTD has been profitable.
  • Each year in the past 5 years MTD had a positive operating cash flow.
MTD Yearly Net Income VS EBIT VS OCF VS FCFMTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • MTD has a Return On Assets of 23.41%. This is amongst the best in the industry. MTD outperforms 100.00% of its industry peers.
  • The Return On Invested Capital of MTD (37.49%) is better than 98.28% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MTD is significantly above the industry average of 12.04%.
Industry RankSector Rank
ROA 23.41%
ROE N/A
ROIC 37.49%
ROA(3y)24.52%
ROA(5y)24.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.42%
ROIC(5y)40.53%
MTD Yearly ROA, ROE, ROICMTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2K -2K

1.3 Margins

  • MTD has a better Profit Margin (21.59%) than 98.28% of its industry peers.
  • MTD's Profit Margin has improved in the last couple of years.
  • The Operating Margin of MTD (28.20%) is better than 98.28% of its industry peers.
  • MTD's Operating Margin has improved in the last couple of years.
  • MTD has a better Gross Margin (59.37%) than 79.31% of its industry peers.
  • MTD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 28.2%
PM (TTM) 21.59%
GM 59.37%
OM growth 3Y-0.93%
OM growth 5Y1.75%
PM growth 3Y-1.02%
PM growth 5Y2.02%
GM growth 3Y0.28%
GM growth 5Y0.34%
MTD Yearly Profit, Operating, Gross MarginsMTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MTD is creating value.
  • Compared to 1 year ago, MTD has less shares outstanding
  • MTD has less shares outstanding than it did 5 years ago.
  • MTD has a better debt/assets ratio than last year.
MTD Yearly Shares OutstandingMTD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
MTD Yearly Total Debt VS Total AssetsMTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • MTD has a debt to FCF ratio of 2.54. This is a good value and a sign of high solvency as MTD would need 2.54 years to pay back of all of its debts.
  • MTD's Debt to FCF ratio of 2.54 is amongst the best of the industry. MTD outperforms 86.21% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.54
Altman-Z N/A
ROIC/WACC3.48
WACC10.76%
MTD Yearly LT Debt VS Equity VS FCFMTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that MTD should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.14, MTD is not doing good in the industry: 81.03% of the companies in the same industry are doing better.
  • MTD has a Quick Ratio of 1.14. This is a bad value and indicates that MTD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of MTD (0.81) is worse than 87.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.81
MTD Yearly Current Assets VS Current LiabilitesMTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • MTD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.96%.
  • Measured over the past years, MTD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.85% on average per year.
  • MTD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.98%.
  • Measured over the past years, MTD shows a small growth in Revenue. The Revenue has been growing by 5.47% on average per year.
EPS 1Y (TTM)3.96%
EPS 3Y2.67%
EPS 5Y10.85%
EPS Q2Q%7.66%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y0.9%
Revenue growth 5Y5.47%
Sales Q2Q%8.1%

3.2 Future

  • MTD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.89% yearly.
  • MTD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.14% yearly.
EPS Next Y8.04%
EPS Next 2Y9.41%
EPS Next 3Y10.54%
EPS Next 5Y10.89%
Revenue Next Year4.8%
Revenue Next 2Y4.76%
Revenue Next 3Y4.85%
Revenue Next 5Y5.14%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MTD Yearly Revenue VS EstimatesMTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B 5B
MTD Yearly EPS VS EstimatesMTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20 40 60 80

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 32.07, MTD can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, MTD is valued a bit cheaper than the industry average as 60.34% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of MTD to the average of the S&P500 Index (27.27), we can say MTD is valued inline with the index average.
  • Based on the Price/Forward Earnings ratio of 29.68, the valuation of MTD can be described as expensive.
  • Based on the Price/Forward Earnings ratio, MTD is valued a bit cheaper than the industry average as 62.07% of the companies are valued more expensively.
  • MTD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 32.07
Fwd PE 29.68
MTD Price Earnings VS Forward Price EarningsMTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 60.34% of the companies in the same industry are more expensive than MTD, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, MTD is valued a bit cheaper than 68.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.87
EV/EBITDA 23.83
MTD Per share dataMTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MTD does not grow enough to justify the current Price/Earnings ratio.
  • MTD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.99
PEG (5Y)2.96
EPS Next 2Y9.41%
EPS Next 3Y10.54%

0

5. Dividend

5.1 Amount

  • No dividends for MTD!.
Industry RankSector Rank
Dividend Yield 0%

METTLER-TOLEDO INTERNATIONAL

NYSE:MTD (2/19/2026, 1:56:05 PM)

1372.1

-3.47 (-0.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners103.22%
Inst Owner Change-0.32%
Ins Owners0.43%
Ins Owner Change3.33%
Market Cap27.89B
Revenue(TTM)4.03B
Net Income(TTM)869.19M
Analysts72.38
Price Target1535.88 (11.94%)
Short Float %2.66%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.56%
Min EPS beat(2)3.34%
Max EPS beat(2)3.78%
EPS beat(4)4
Avg EPS beat(4)3.47%
Min EPS beat(4)2.78%
Max EPS beat(4)3.98%
EPS beat(8)8
Avg EPS beat(8)5.09%
EPS beat(12)10
Avg EPS beat(12)2.81%
EPS beat(16)14
Avg EPS beat(16)3.29%
Revenue beat(2)2
Avg Revenue beat(2)1.74%
Min Revenue beat(2)1.23%
Max Revenue beat(2)2.25%
Revenue beat(4)3
Avg Revenue beat(4)1.23%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)2.25%
Revenue beat(8)7
Avg Revenue beat(8)1.58%
Revenue beat(12)8
Avg Revenue beat(12)0.39%
Revenue beat(16)12
Avg Revenue beat(16)0.67%
PT rev (1m)0.86%
PT rev (3m)14.03%
EPS NQ rev (1m)-2.28%
EPS NQ rev (3m)-5.88%
EPS NY rev (1m)0.56%
EPS NY rev (3m)-0.53%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)1.99%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)1.56%
Valuation
Industry RankSector Rank
PE 32.07
Fwd PE 29.68
P/S 6.93
P/FCF 32.87
P/OCF 29.19
P/B N/A
P/tB N/A
EV/EBITDA 23.83
EPS(TTM)42.79
EY3.12%
EPS(NY)46.23
Fwd EY3.37%
FCF(TTM)41.74
FCFY3.04%
OCF(TTM)47.01
OCFY3.43%
SpS198.05
BVpS-1.16
TBVpS-51.24
PEG (NY)3.99
PEG (5Y)2.96
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 23.41%
ROE N/A
ROCE 45.15%
ROIC 37.49%
ROICexc 38.52%
ROICexgc 65.95%
OM 28.2%
PM (TTM) 21.59%
GM 59.37%
FCFM 21.08%
ROA(3y)24.52%
ROA(5y)24.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.42%
ROIC(5y)40.53%
ROICexc(3y)42.66%
ROICexc(5y)41.98%
ROICexgc(3y)76.93%
ROICexgc(5y)75.65%
ROCE(3y)49.88%
ROCE(5y)48.8%
ROICexgc growth 3Y-3.59%
ROICexgc growth 5Y2.43%
ROICexc growth 3Y-2.82%
ROICexc growth 5Y1.79%
OM growth 3Y-0.93%
OM growth 5Y1.75%
PM growth 3Y-1.02%
PM growth 5Y2.02%
GM growth 3Y0.28%
GM growth 5Y0.34%
F-Score6
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.54
Debt/EBITDA 1.66
Cap/Depr 85.28%
Cap/Sales 2.66%
Interest Coverage 250
Cash Conversion 75.8%
Profit Quality 97.64%
Current Ratio 1.14
Quick Ratio 0.81
Altman-Z N/A
F-Score6
WACC10.76%
ROIC/WACC3.48
Cap/Depr(3y)85.51%
Cap/Depr(5y)92.66%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.82%
Profit Quality(3y)102.3%
Profit Quality(5y)99.13%
High Growth Momentum
Growth
EPS 1Y (TTM)3.96%
EPS 3Y2.67%
EPS 5Y10.85%
EPS Q2Q%7.66%
EPS Next Y8.04%
EPS Next 2Y9.41%
EPS Next 3Y10.54%
EPS Next 5Y10.89%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y0.9%
Revenue growth 5Y5.47%
Sales Q2Q%8.1%
Revenue Next Year4.8%
Revenue Next 2Y4.76%
Revenue Next 3Y4.85%
Revenue Next 5Y5.14%
EBIT growth 1Y0.3%
EBIT growth 3Y-0.04%
EBIT growth 5Y7.31%
EBIT Next Year13.48%
EBIT Next 3Y9.32%
EBIT Next 5Y8.58%
FCF growth 1Y-1.83%
FCF growth 3Y4.77%
FCF growth 5Y6.07%
OCF growth 1Y-1.3%
OCF growth 3Y3.62%
OCF growth 5Y5.69%

METTLER-TOLEDO INTERNATIONAL / MTD FAQ

What is the fundamental rating for MTD stock?

ChartMill assigns a fundamental rating of 5 / 10 to MTD.


What is the valuation status of METTLER-TOLEDO INTERNATIONAL (MTD) stock?

ChartMill assigns a valuation rating of 4 / 10 to METTLER-TOLEDO INTERNATIONAL (MTD). This can be considered as Fairly Valued.


Can you provide the profitability details for METTLER-TOLEDO INTERNATIONAL?

METTLER-TOLEDO INTERNATIONAL (MTD) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for MTD stock?

The Price/Earnings (PE) ratio for METTLER-TOLEDO INTERNATIONAL (MTD) is 32.07 and the Price/Book (PB) ratio is -1180.18.


Can you provide the expected EPS growth for MTD stock?

The Earnings per Share (EPS) of METTLER-TOLEDO INTERNATIONAL (MTD) is expected to grow by 8.04% in the next year.